# Intravesical BCG Administration to Patients With Invasive Bladder Cancer

> **NCT02365207** · NA · TERMINATED · sponsor: **The University of Texas Health Science Center at San Antonio** · enrollment: 6 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** BCG strain of Mycobacterium bovis

## Key facts

- **NCT ID:** NCT02365207
- **Lead sponsor:** The University of Texas Health Science Center at San Antonio
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2018-09-30
- **Final completion:** 2019-04-25
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Poor accrual of subjects and lack of funding
- **Last updated:** 2019-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365207

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365207, "Intravesical BCG Administration to Patients With Invasive Bladder Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02365207. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*